:: Volume 7, Issue 3 (7-2016) ::
Caspian J Intern Med 2016, 7(3): 162-167 Back to browse issues page
A five years study on the epidemiological approaches of Cholera in Iran
Moharam Mafi , Massoud Hajia , Mohamad-mahdi Goya
Research center of Health Reference Laboratories, Ministry of Health and Medical Education, Tehran, Iran , massoudhajia@yahoo.com
Abstract:   (7293 Views)

Background: Cholera is considered a key indicator of social development but still is reported in various cities of Iran. The present study aimed to analyze the available information regarding cholera outbreaks since 2010 in Iran.

Methods: All cases reported to the Center for Disease Control and Prevention of Ministry of Health and Education who had been confirmed as cholera cases by the Health Reference Laboratory, were entered into this study since 2010. A specific spreadsheet was designed to ensure the safe keeping of the patient records.

Results: A total of 1522 patients were clinically diagnosed as cholera with laboratory confirmation over the study period. Cholera was detected in 26 Provinces and 115 cities during this period. Mean age of the patients was 35.1±17, both the Inaba and Ogawa strains were isolated. The highest mortality and the morbidity rate was 1.98% in 2013. The most cholera prevalent provinces in order of frequency were Baluchistan, Alborz, Gilan, Golestan and Qom, as well as Tehran. Inaba serotype was the most common cause of mortality and morbidity in 2013.

Conclusion: These findings indicate significant outbreaks of cholera in some of the provinces of Iran and warrant appropriate treatment and preventive measures.

Keywords: Epidemiology, Risk factor, Cholera
Full-Text [PDF 304 kb]   (2835 Downloads)    
Type of Study: Original Article | Subject: Microbiology
Received: 2015/07/28 | Accepted: 2015/11/18 | Published: 2016/06/7


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 3 (7-2016) Back to browse issues page